tiprankstipranks
Advertisement
Advertisement

HK:1652 Stock Latest News

Fusen Pharmaceutical Extends Completion Date for Henan Equity Transaction
Company AnnouncementsFusen Pharmaceutical Extends Completion Date for Henan Equity Transaction
3d ago
1652
Fusen Pharmaceutical Wins China Approval for New Doxazosin Extended-Release Tablets
PremiumCompany Announcements
Fusen Pharmaceutical Wins China Approval for New Doxazosin Extended-Release Tablets
23d ago
1652
Fusen Pharmaceutical Shareholders Approve RMB300 Million Capital Injection into Henan Subsidiary
PremiumCompany Announcements
Fusen Pharmaceutical Shareholders Approve RMB300 Million Capital Injection into Henan Subsidiary
24d ago
1652
Fusen Pharmaceutical Wins China Nod for Peramivir Flu Injection
PremiumCompany Announcements
Fusen Pharmaceutical Wins China Nod for Peramivir Flu Injection
1M ago
1652
Fusen Pharmaceutical Seeks Shareholder Approval for RMB300 Million Capital Injection
PremiumCompany Announcements
Fusen Pharmaceutical Seeks Shareholder Approval for RMB300 Million Capital Injection
1M ago
1652
Fusen Pharmaceutical to Dilute Stake in Henan Unit via RMB300 Million Capital Increase
PremiumCompany AnnouncementsFusen Pharmaceutical to Dilute Stake in Henan Unit via RMB300 Million Capital Increase
2M ago
1652
Fusen Pharmaceutical Sets July EGM to Approve Capital Increase Plan
Premium
Company Announcements
Fusen Pharmaceutical Sets July EGM to Approve Capital Increase Plan
2M ago
1652
Fusen Pharma Wins China Approval for New Piracetam Injection Formats
Premium
Company Announcements
Fusen Pharma Wins China Approval for New Piracetam Injection Formats
2M ago
1652
Fusen Pharmaceutical Wins China Nod to Market Agomelatine Antidepressant
PremiumCompany Announcements
Fusen Pharmaceutical Wins China Nod to Market Agomelatine Antidepressant
2M ago
1652
Fusen Pharmaceutical Shareholders Approve All AGM Resolutions, Renew Capital Mandates
PremiumCompany Announcements
Fusen Pharmaceutical Shareholders Approve All AGM Resolutions, Renew Capital Mandates
2M ago
1652
Fusen Pharmaceutical Wins China Approval for New Lornoxicam Injection
PremiumCompany Announcements
Fusen Pharmaceutical Wins China Approval for New Lornoxicam Injection
3M ago
1652
Fusen Pharmaceutical Sets 2026 AGM to Renew Board, Auditor and Share Issuance Mandate
PremiumCompany Announcements
Fusen Pharmaceutical Sets 2026 AGM to Renew Board, Auditor and Share Issuance Mandate
3M ago
1652
Fusen Pharma Wins Mainland China Approval for New Dydrogesterone Tablet
PremiumCompany AnnouncementsFusen Pharma Wins Mainland China Approval for New Dydrogesterone Tablet
3M ago
1652
Fusen Pharmaceutical Wins China Approval for Glucosamine Osteoarthritis Capsule
Premium
Company Announcements
Fusen Pharmaceutical Wins China Approval for Glucosamine Osteoarthritis Capsule
4M ago
1652
Fusen Pharmaceutical Switches Auditor After Dispute Over 2025 Audit Fee
Premium
Company Announcements
Fusen Pharmaceutical Switches Auditor After Dispute Over 2025 Audit Fee
4M ago
1652
Fusen Pharmaceutical Narrows Annual Loss Despite Revenue Decline
PremiumCompany Announcements
Fusen Pharmaceutical Narrows Annual Loss Despite Revenue Decline
4M ago
1652
Fusen Pharmaceutical Sets March 2026 Board Meeting to Approve 2025 Results
PremiumCompany Announcements
Fusen Pharmaceutical Sets March 2026 Board Meeting to Approve 2025 Results
5M ago
1652
Fusen Pharmaceutical Wins China Approval for New Phosphate Injection
PremiumCompany Announcements
Fusen Pharmaceutical Wins China Approval for New Phosphate Injection
7M ago
1652
Fusen Pharmaceutical Replaces KPMG With CCTH as Auditor to Cut Costs
PremiumCompany Announcements
Fusen Pharmaceutical Replaces KPMG With CCTH as Auditor to Cut Costs
7M ago
1652
Fusen Pharmaceutical Gains Approval for Nicardipine Hydrochloride Injection
PremiumCompany AnnouncementsFusen Pharmaceutical Gains Approval for Nicardipine Hydrochloride Injection
8M ago
1652
Fusen Pharmaceutical’s New Hypertension Drug Gains Approval in China
Premium
Company Announcements
Fusen Pharmaceutical’s New Hypertension Drug Gains Approval in China
9M ago
1652
Fusen Pharmaceutical’s Enzalutamide Soft Capsule Approved for Prostate Cancer Treatment in China
Premium
Company Announcements
Fusen Pharmaceutical’s Enzalutamide Soft Capsule Approved for Prostate Cancer Treatment in China
9M ago
1652

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >